AMANDA WALLACE: Open Payments
NPI 1275104796 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 70 payments from 13 companies in 2025. Trend: 2023 $1,505 · 2024 $1,773 · 2025 $1,847
Food & beverage: $1,677Education: $170
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 7 | $272 |
| Astellas Pharma US Inc | 4 | $228 |
| ABBVIE INC. | 9 | $224 |
| Gilead Sciences, Inc. | 10 | $204 |
| ViiV Healthcare Company | 7 | $201 |
| Aimmune Therapeutics, Inc. | 10 | $172 |
| Insmed, Inc. | 6 | $169 |
| Merck Sharp & Dohme LLC | 4 | $102 |
| La Jolla Pharmaceutical Company | 3 | $84 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $65 |
Products named: Rezzayo, Arikayce, VOWST, MAVYRET, ZEVTERA, DOVATO, XERAVA, NUZYRA.
Industry payments across FL — which companies pay providers there.
